FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects

<!–

–>

<!–

• Page Last Updated: 07/29/2013

–>
Page Last Updated: 07/29/2013
<!–

–>

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.